![]() |
Name |
6-Amino-1-hexanol, TMS derivative
|
Molecular Formula | C9H23NOSi | |
IUPAC Name* |
6-trimethylsilyloxyhexan-1-amine
|
|
SMILES |
C[Si](C)(C)OCCCCCCN
|
|
InChI |
InChI=1S/C9H23NOSi/c1-12(2,3)11-9-7-5-4-6-8-10/h4-10H2,1-3H3
|
|
InChIKey |
LYCNGDWFSVYEHD-UHFFFAOYSA-N
|
|
Synonyms |
6-Amino-1-hexanol, TMS derivative; 1-Hexanol, 6-amino, O-TMS; 6-Amino-1-hexanol, trimethylsilyl ether; 6-[(Trimethylsilyl)oxy]hexan-1-amine #
|
|
CAS | NA | |
PubChem CID | 529165 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 189.37 | ALogp: | 2.4 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 35.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 12 | QED Weighted: | 0.493 |
Caco-2 Permeability: | -5.026 | MDCK Permeability: | 0.00009590 |
Pgp-inhibitor: | 0.622 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.046 | Plasma Protein Binding (PPB): | 72.05% |
Volume Distribution (VD): | 1.716 | Fu: | 13.01% |
CYP1A2-inhibitor: | 0.696 | CYP1A2-substrate: | 0.922 |
CYP2C19-inhibitor: | 0.053 | CYP2C19-substrate: | 0.86 |
CYP2C9-inhibitor: | 0.021 | CYP2C9-substrate: | 0.678 |
CYP2D6-inhibitor: | 0.019 | CYP2D6-substrate: | 0.855 |
CYP3A4-inhibitor: | 0.047 | CYP3A4-substrate: | 0.2 |
Clearance (CL): | 5.308 | Half-life (T1/2): | 0.578 |
hERG Blockers: | 0.086 | Human Hepatotoxicity (H-HT): | 0.158 |
Drug-inuced Liver Injury (DILI): | 0.028 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.06 | Maximum Recommended Daily Dose: | 0.034 |
Skin Sensitization: | 0.895 | Carcinogencity: | 0.085 |
Eye Corrosion: | 0.999 | Eye Irritation: | 0.452 |
Respiratory Toxicity: | 0.974 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001178 | ![]() |
0.906 | D0FD0H | ![]() |
0.333 | ||
ENC003082 | ![]() |
0.404 | D0AY9Q | ![]() |
0.276 | ||
ENC000897 | ![]() |
0.390 | D05ATI | ![]() |
0.254 | ||
ENC001268 | ![]() |
0.368 | D0V8PA | ![]() |
0.241 | ||
ENC000621 | ![]() |
0.347 | D05QNO | ![]() |
0.231 | ||
ENC000459 | ![]() |
0.341 | D0Z5SM | ![]() |
0.229 | ||
ENC000268 | ![]() |
0.340 | D01QLH | ![]() |
0.227 | ||
ENC000855 | ![]() |
0.333 | D0E4WR | ![]() |
0.218 | ||
ENC000854 | ![]() |
0.327 | D0Y8DP | ![]() |
0.217 | ||
ENC000279 | ![]() |
0.327 | D0Z5BC | ![]() |
0.214 |